Home › Funds › Geode Capital Management › CTOR
Geode Capital Management position in CTOR
CLOVIS ONCOLOGY INC · Health Care
Latest position (Q2 2026)245.41K sh
Reported value held$159.54K
Portfolio Weight0.00%
First reportedQ4 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 12.65K | $14.55K | New |
| Q1 2025 | 20.54K | $19.10K | Add |
| Q2 2025 | 57.30K | $249.24K | Add |
| Q3 2025 | 167.17K | $339.36K | Add |
| Q4 2025 | 220.05K | $220.05K | Add |
| Q1 2026 | 264.73K | $164.11K | Add |
| Q2 2026 | 245.41K | $159.54K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CTOR
- Bank of America Corp 3.84M sh · $2.49M · Q2 2026
- Vanguard Group 597.00K sh · $597.00K · Q4 2025
- UBS Group AG 334.62K sh · $217.50K · Q2 2026
- Citadel Advisors 90.59K sh · $58.89K · Q2 2026
- Northern Trust Corp 45.75K sh · $29.74K · Q2 2026
- Wells Fargo & Co 500 sh · $325 · Q2 2026
- Morgan Stanley 23 sh · $15 · Q2 2026